LensGen Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 11

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $5.9M

  • Investors
  • 5

LensGen General Information

Description

Developer of an ophthalmic medical device designed to treat cataracts and presbyopia. The company's device detects eyesight problems by mimicking the eye's natural accommodation process to change shape and adjust focus, enabling patients with cataracts and presbyopia to permanently restore clear and continuous vision at all distances.

Contact Information

Website
www.lensgen.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 15310 Barranca Parkway
  • Suite 200
  • Irvine, CA 92618
  • United States
+1 (949)
Primary Industry
Therapeutic Devices
Corporate Office
  • 15310 Barranca Parkway
  • Suite 200
  • Irvine, CA 92618
  • United States
+1 (949)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

LensGen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC 02-Mar-2023 $5.9M Completed Generating Revenue
8. Later Stage VC (Series B) 01-Jan-2022 Completed Clinical Trials - Phase 1
7. Secondary Transaction - Private 01-Sep-2021 Completed Clinical Trials - Phase 1
6. Later Stage VC 20-Aug-2020 Completed Clinical Trials - Phase 1
5. Later Stage VC (Series A2) 01-May-2017 Completed Clinical Trials - Phase 1
4. Later Stage VC (Series A1) 01-Sep-2016 Completed Clinical Trials - Phase 1
3. Early Stage VC 16-Nov-2014 Completed Startup
2. Accelerator/Incubator 01-Apr-2014 $4.5M Completed Startup
1. Early Stage VC 10-Sep-2013 $4.5M $4.5M Completed Startup
To view LensGen’s complete valuation and funding history, request access »

LensGen Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-2
Series A-1
Seed 2,526,726 $0.000100 8% $0.95 $0.95 1x $0.95 4.83%
To view LensGen’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

LensGen Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an ophthalmic medical device designed to treat cataracts and presbyopia. The company's device detects eyesi
Therapeutic Devices
Irvine, CA
11 As of 2026

Jacksonville, FL
 

Geneva, Switzerland
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

LensGen Competitors (2)

One of LensGen’s 2 competitors is Johnson & Johnson Vision Care, a Corporate Backed or Acquired company based in Jacksonville, FL.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Johnson & Johnson Vision Care Corporate Backed or Acquired Jacksonville, FL
Alcon Corporate Backed or Acquired Geneva, Switzerland
You’re viewing 2 of 2 competitors. Get the full list »

LensGen Patents

LensGen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2020398888-A1 Fluid lens component for intraocular lens and methods of preparing the same Inactive 11-Dec-2019
EP-4072472-A1 Fluid lens component for intraocular lens and methods of preparing the same Inactive 11-Dec-2019
EP-4072472-A4 Fluid lens component for intraocular lens and methods of preparing the same Inactive 11-Dec-2019
US-20230044397-A1 Fluid lens component for intraocular lens and methods of preparing the same Pending 11-Dec-2019
WO-2021119174-A1 Fluid lens component for intraocular lens and methods of preparing the same Inactive 11-Dec-2019 A61F2/1635
To view LensGen’s complete patent history, request access »

LensGen Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

LensGen Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Auctus Global Capital Venture Capital Minority
Hoya Corporation Minority
Relativity Healthcare Partners Venture Capital Minority
ExSight Ventures Venture Capital Minority
MedTech Innovator Accelerator/Incubator Minority
To view LensGen’s complete investors history, request access »

LensGen FAQs

  • When was LensGen founded?

    LensGen was founded in 2011.

  • Where is LensGen headquartered?

    LensGen is headquartered in Irvine, CA.

  • What is the size of LensGen?

    LensGen has 11 total employees.

  • What industry is LensGen in?

    LensGen’s primary industry is Therapeutic Devices.

  • Is LensGen a private or public company?

    LensGen is a Private company.

  • What is LensGen’s current revenue?

    The current revenue for LensGen is .

  • How much funding has LensGen raised over time?

    LensGen has raised $90.8M.

  • Who are LensGen’s investors?

    Auctus Global Capital, Hoya, Relativity Healthcare Partners, ExSight Ventures, and MedTech Innovator have invested in LensGen.

  • Who are LensGen’s competitors?

    Johnson & Johnson Vision Care and Alcon are competitors of LensGen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process